-
Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis Fertil. Steril. (IF 6.6) Pub Date : 2024-06-27 Kim van der Ham M.D., Joop S.E. Laven Ph.D., Chau Thien Tay Ph.D., Aya Mousa Ph.D., Helena Teede Ph.D., Yvonne V. Louwers Ph.D.
As part of the 2023 international evidence-based polycystic ovary syndrome (PCOS) guideline, this meta-analysis investigated the inclusion of Anti-Müllerian hormone (AMH) levels in the diagnostic criteria for PCOS. To answer the following three questions: 1) Are AMH levels effective in diagnosing PCOS in adult women? 2) Are AMH levels effective in diagnosing PCOS in adolescents? Are AMH levels effective
-
The role of minimal residual disease assessment in ovarian tissue cryopreservation among oncofertility cases Fertil. Steril. (IF 6.6) Pub Date : 2024-06-19 Mohd Faizal Ahmad M.D., Marjanu Hikmah Elias M.Sc. Ph.D.
-
Expectant management? How to communicate realistic outcomes and the possibility of failure Fertil. Steril. (IF 6.6) Pub Date : 2024-06-19 Kiley Hunkler M.D. M.St. M.Sc., Eric Widra M.D.
-
Seeds of hope: fertility support in resource-limited settings Fertil. Steril. (IF 6.6) Pub Date : 2024-06-14 Robert J. Norman M.D., Bart C.J. M. Fauser M.D. Ph.D.
-
Racial and ethnic disparities in wait times for donor oocytes Fertil. Steril. (IF 6.6) Pub Date : 2024-06-08 Shelun Tsai M.D., Nissiya Adjei B.S., Angela D. Svedberg B.Ed., Anjile An M.P.H., Callie Rose Sacks B.A., Jonas Malmsten D.P.S., Zev Rosenwaks M.D., Alexis P. Melnick M.D.
-
Maternal stress in pregnancy and pubertal timing in girls and boys: a cohort study Fertil. Steril. (IF 6.6) Pub Date : 2024-06-05 Anne Gaml-Sørensen Ph.D., Nis Brix Ph.D., Tine B. Henriksen Ph.D., Cecilia H. Ramlau-Hansen Ph.D.
To investigate whether maternal stress in pregnancy is associated with pubertal timing in girls and boys and to explore potential mediation by childhood body mass index (BMI) and childhood psychosocial stress. Cohort study. Not applicable. In total, 14,702 girls and boys from the Puberty Cohort, nested within the Danish National Birth Cohort. Maternal stress was obtained from a computer-assisted telephone
-
Minimum number of mature oocytes needed to obtain at least one euploid blastocyst according to female age in in vitro fertilization treatment cycles Fertil. Steril. (IF 6.6) Pub Date : 2024-06-05 Cristina Rodríguez-Varela M.Sc., Juan Manuel Mascarós M.Sc., Elena Labarta M.D. Ph.D., Noelia Silla M.Sc., Ernesto Bosch M.D. Ph.D
To find a useful tool for estimating the minimum number of metaphase II (MII) oocytes needed to obtain at least one euploid blastocyst according to female age. Retrospective analysis of in vitro fertilization (IVF) treatment cycles with preimplantational genetic testing for aneuploidies (PGT-A) performed over 5 years in IVIRMA Valencia (Spain), January 2017–March 2022. Approval from the Institutional
-
In vitro fertilization and perinatal outcomes of patients with advanced maternal age after single frozen euploid embryo transfer: a propensity score-matched analysis of autologous and donor cycles Fertil. Steril. (IF 6.6) Pub Date : 2024-06-03 Mauro Cozzolino M.D. Ph.D., Antonio Capalbo Ph.D., Juan Antonio Garcia-Velasco M.D. Ph.D., Antonio Pellicer M.D. Ph.D., Alberto Vaiarelli M.D. Ph.D., Daniela Galliano M.D. Ph.D., Danilo Cimadomo M.Sc. Ph.D., Filippo Maria Ubaldi M.D. Ph.D., Valentina Parini M.Sc., Paolo Emanuele Levi-Setti M.D.
To evaluate in vitro fertilization (IVF) and perinatal outcomes of donor egg and autologous cycles in patients with advanced reproductive age after undergoing single frozen euploid embryo transfer. A multicenter, retrospective, cohort study. University-affiliated and private IVF centers. Patients aged 39–46 years who underwent IVF with intracytoplasmic sperm injection and preimplantation genetic testing
-
Clinical procedures for in vitro maturation treatment Fertil. Steril. (IF 6.6) Pub Date : 2024-06-03 Michel De Vos M.D., Ingrid Segers Ph.D., Ye Yuan Ph.D., Robert B. Gilchrist Ph.D., Christian C. Kramme Ph.D.
To demonstrate clinical techniques for in vitro maturation (IVM) treatment, including stimulation recommendations, small follicle pick-up procedures, and compact cumulus-oocyte complex (COC) search practice. This video utilizes live-action footage from surgery and embryology practice for a representative IVM treatment cycle, with step-by-step instructions and recommendations for practice procedures
-
Obstetric outcomes in women with pelvic endometriosis: a prospective cohort study Fertil. Steril. (IF 6.6) Pub Date : 2024-06-03 Elisabeth M.R. Bean M.B.B.S. B.Sc., Jure Knez M.D., Nikolaos Thanatsis M.D. Ph.D., Lucrezia De Braud M.D., Fatima Taki M.B.B.S. B.Sc., Martin Hirsch M.B.B.S. B.Sc., Anna David M.B.B.S. B.Sc. Ph.D., Davor Jurkovic M.D. Ph.D.
To determine whether obstetric outcomes differ between women with endometriosis and those without, where all women undergo first-trimester screening for endometriosis. A prospective observational cohort study. The Early Pregnancy Unit at University College London Hospital, United Kingdom. Women with a live pregnancy progressing beyond 12 weeks’ gestation and concurrent endometriosis (n = 110) or no
-
Ovarian tissue cryopreservation in pediatric patients with malignancy involving the ovary Fertil. Steril. (IF 6.6) Pub Date : 2024-06-03 Melissa J. Bak B.A., Doris Farje M.D., Elizabeth L. Tsui B.S., Timothy B. Lautz M.D., Monica M. Laronda Ph.D., Erin E. Rowell M.D.
-
Effects of a eucaloric high-fat diet on anterior pituitary hormones and adipocytokines in women with normal weight Fertil. Steril. (IF 6.6) Pub Date : 2024-06-03 Thy Nguyen B.A., Katherine Kuhn M.S., Angela Fought M.S., Matthew Bolt M.S., Andrew P. Bradford Ph.D., Nanette Santoro M.D.
-
Imprinting disorders in children conceived with assisted reproductive technology in Sweden Fertil. Steril. (IF 6.6) Pub Date : 2024-06-01 Mujin Ye M.D., Arturo Reyes Palomares Ph.D., Erik Iwarsson M.D. Ph.D., Anna S. Oberg M.D. Ph.D., Kenny A. Rodriguez-Wallberg M.D. Ph.D.
To assess whether the use of assisted reproductive technology (ART) therapy for conception is associated with imprinting disorders in children and the impact of parental factors related to infertility. A nationwide register-based cohort study. Swedish national registers and nationwide quality IVF register. All liveborn singletons in Sweden (N = 2,084,127) between 1997 and 2017 with follow-up to December
-
Outcomes of thoracic endometriosis in pregnant women Fertil. Steril. (IF 6.6) Pub Date : 2024-06-01 Anne Gompel M.D. Ph.D., Hélène Thomas M.D., Geneviève Plu-Bureau M.D. Ph.D., Marco Alifano M.D. Ph.D.
-
The use of preimplantation genetic testing for aneuploidy: a committee opinion Fertil. Steril. (IF 6.6) Pub Date : 2024-06-01 Raoul Orvieto M.D. M.M.Sc.
-
Rethinking the exclusion of obese women from infertility care Fertil. Steril. (IF 6.6) Pub Date : 2024-06-01 Qian Feng M.B. B.S. M.Sc., Ben W. Mol M.D. Ph.D.
-
Clinical dilemmas in ovarian tissue cryopreservation Fertil. Steril. (IF 6.6) Pub Date : 2024-05-31 Cheryl E. Dunlop M.D. Ph.D., Richard A. Anderson M.D. Ph.D.
Ovarian tissue cryopreservation (OTC) is increasingly offered globally as a fertility preservation strategy for both postpubertal women and prepubertal girls, with subsequent reimplantation of cryopreserved ovarian cortex resulting in a rapidly growing number of live births. There remains very limited evidence of efficacy from tissue stored when the patient was prepubertal or from conditions affecting
-
-
Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists Fertil. Steril. (IF 6.6) Pub Date : 2024-05-27 Alyse S. Goldberg M.D., Christina E. Boots M.D. M.S.C.I.
The objective of this narrative review is to advocate for improved comprehensive care of patients with obesity and infertility. Persons with an increased body mass index have less successful reproductive outcomes, and recently, new medications to treat neuroendocrine hormone imbalances are producing meaningful weight loss akin to surgical interventions. For the first time, obesity is publicly being
-
Response to Arian and Mostafaei Fertil. Steril. (IF 6.6) Pub Date : 2024-05-24 Jack Wilkinson Ph.D., Katie Stocking M.Sc.
-
Embryos derived from single pronucleus are suitable for preimplantation genetic testing Fertil. Steril. (IF 6.6) Pub Date : 2024-05-23 Oshrit Lebovitz M.D., Meirav Noach-Hirsh Ph.D., Sarah Taieb B.Sc., Jigal Haas M.D., Eran Zilberberg M.D., Ravit Nahum M.D., Raoul Orvieto M.D., Adva Aizer Ph.D.
To study and compare the preimplantation genetic testing for monogenic disorders (PGT-M) results, and to evaluate the treatment cycle outcomes of embryos derived from a single pronucleus (1PN) vs. two pronuclei (2PN). A retrospective cohort study from January 2018 to December 2022 involving in vitro fertilization (IVF)-PGT-M treatment cycles. Single, academically affiliated fertility center. A total
-
Inverse association of prepregnancy systolic blood pressure and live birth rate in normotensive women undergoing in vitro fertilization/intracytoplasmic sperm injection Fertil. Steril. (IF 6.6) Pub Date : 2024-05-22 Shujuan Ma Ph.D., Liang Hu Ph.D., Huijun Chen M.D., Yvonne Liu M.D., Johann-Georg Hocher M.D., XiangWang Xu M.S., Fei Gong Ph.D., Bernhard K. Krämer Ph.D., Ge Lin Ph.D., Berthold Hocher Ph.D.
To explore whether maternal baseline systolic blood pressure (SBP) and diastolic blood pressure (DBP) affect pregnancy outcomes particularly in normotensive women (SBP, 90–139 mm Hg; DBP, 60–89 mm Hg) and hypertensive women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Retrospective cohort study. Maximum care hospital for reproductive medicine. This study included
-
Educational gradients in the prevalence of medically assisted reproduction births in a comparative perspective Fertil. Steril. (IF 6.6) Pub Date : 2024-05-19 Alice Goisis Ph.D., Peter Fallesen Ph.D., Marta Seiz Ph.D., Leire Salazar Ph.D., Tatiana Eremenko Ph.D., Marco Cozzani Ph.D.
To study educational gradients in births after medically assisted reproduction across 5 countries with different institutional arrangements. We use logistic regression and compute predicted probabilities to estimate the association between education and giving birth after assisted reproduction, before and after adjustment for maternal age at delivery and marital/partnership status, using an overall
-
The use of preimplantation genetic testing for aneuploidy: a committee opinion Fertil. Steril. (IF 6.6) Pub Date : 2024-05-18 Practice Committee of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology
-
Time to change the culture of assisted hatching in frozen embryo transfers Fertil. Steril. (IF 6.6) Pub Date : 2024-05-17 Kerri E. Andre M.D., Heather S. Hipp M.D.
-
Bilateral labiocrural fasciocutaneous flaps for vaginoplasty: when two become one Fertil. Steril. (IF 6.6) Pub Date : 2024-05-16 Phillip A. Romanski M.D. M.Sc., Pietro Bortoletto M.D. M.Sc., Samantha M. Pfeifer M.D.
-
The experiences of parents with a child born after preimplantation genetic testing Fertil. Steril. (IF 6.6) Pub Date : 2024-05-14 Vasanti Jadva Ph.D., Kate Shaw B.A., Bjørn Bay Ph.D., Michelle Poulsen M.Sc., Hans Jakob Ingerslev M.D. D.M.Sc., Morten Rønn Petersen D.V.M. Ph.D., Jens Fedder M.D. Ph.D., Ulrik Schiøler Kesmodel Ph.D.
-
Individualized dosing of follitropin delta affects live birth and safety in in vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials Fertil. Steril. (IF 6.6) Pub Date : 2024-05-14 Scott M. Nelson Ph.D., Martin Shaw Ph.D., Karema Alrashid Ph.D., Richard A. Anderson Ph.D.
To undertake a one-stage meta-analysis of individual patient data from randomized trials comparing individualized dosing of follitropin delta vs. other forms of follitropin (alpha and beta) for live birth (LB) rates (LBR) and safety parameters in women undergoing ovarian stimulation for in vitro fertilization treatment. Systematic review with individual patient data meta-analysis. Not applicable. Women
-
Solving the mysteries surrounding uterine fibroids: are we almost there? Fertil. Steril. (IF 6.6) Pub Date : 2024-05-11 Marie-Madeleine Dolmans M.D. Ph.D., Jacques Donnez M.D. Ph.D.
A better understanding of uterine fibroid-related pathogenesis and symptoms like uterine bleeding and infertility is mandatory.
-
The limitations of oocyte donor data for studying reproductive health inequities Fertil. Steril. (IF 6.6) Pub Date : 2024-05-10 Ruth J. Geller M.H.S., Amelia K. Wesselink M.P.H. Ph.D.
-
Should we consider antimüllerian hormone a valid marker of semen quality? Fertil. Steril. (IF 6.6) Pub Date : 2024-05-10 Kevin J. Campbell M.D. M.S.
-
The time is now to change the narrative on preimplantation genetic testing for aneuploidy Fertil. Steril. (IF 6.6) Pub Date : 2024-05-09 Amber R. Cooper M.D. M.S.C.I., Manuel Viotti Ph.D. H.C.L.D.
-
Fresh tools, familiar findings: machine learning in prediction of pregnancy loss Fertil. Steril. (IF 6.6) Pub Date : 2024-05-09 Jesper Friis Petersen M.D. Ph.D., Ellen Løkkegaard M.D. Ph.D.
-
Clinical signs and diagnosis of fibroids from adolescence to menopause Fertil. Steril. (IF 6.6) Pub Date : 2024-05-09 Eduard Mension M.D. Ph.D., Francisco Carmona M.D. Ph.D., Silvia Vannuccini M.D. Ph.D., Charles Chapron M.D. Ph.D.
The aim of this review was to provide an updated assessment of the present diagnostic tools and clinical symptoms and signs to evaluate uterine fibroids (UFs) on the basis of current guidelines, recent scientific evidence, and a PubMed and Google Scholar search for peer-reviewed original and review articles related to clinical signs and diagnosis of UFs. Approximately 50%–75% of UFs are considered
-
Advances in uterine fibroid research: linking progesterone and the transforming growth factor-β signaling pathway Fertil. Steril. (IF 6.6) Pub Date : 2024-05-09 Md Soriful Islam Ph.D.
-
The modern management of uterine fibroids-related abnormal uterine bleeding Fertil. Steril. (IF 6.6) Pub Date : 2024-05-08 Silvia Vannuccini M.D. Ph.D., Felice Petraglia M.D., Francisco Carmona M.D. Ph.D., Joaquim Calaf Ph.D., Charles Chapron M.D. Ph.D.
Uterine fibroids (UFs) are the most common female benign pelvic tumors, affecting >60% of patients aged 30–44 years. Uterine fibroids are asymptomatic in a large percentage of cases and may be identified incidentally using a transvaginal ultrasound or a magnetic resonance imaging scan. However, in approximately 30% of cases, UFs affect the quality of life and women’s health, with abnormal uterine bleeding
-
Ovarian tissue cryopreservation for fertility preservation: with innovation must come the development of guidelines and best practices Fertil. Steril. (IF 6.6) Pub Date : 2024-05-08 Ariella Yazdani M.D., Jawaria Amir M.D., Mindy S. Christianson M.D.
-
Altered endometrial receptivity: back to the future again? Fertil. Steril. (IF 6.6) Pub Date : 2024-05-08 Paul Pirtea M.D., Jim Toner M.D. Ph.D., Richard T. Scott M.D., Dominique de Ziegler M.D. Ph.D.
-
Intrauterine adhesions. A sticky problem without a solution Fertil. Steril. (IF 6.6) Pub Date : 2024-05-08 Jose Carugno M.D., Jude Okohue M.D., Nash Moawad M.D. M.S.
-
Culture time to optimize embryo cell-free DNA analysis for frozen-thawed blastocysts undergoing noninvasive preimplantation genetic testing for aneuploidy Fertil. Steril. (IF 6.6) Pub Date : 2024-05-07 Goli Ardestani Ph.D., Maria Banti M.Sc., Carmen M. García-Pascual Ph.D., Luis Navarro-Sánchez Ph.D., Estee Van Zyl M.Sc., Jose Antonio Castellón M.S., Carlos Simón M.D. Ph.D., Denny Sakkas Ph.D., Carmen Rubio Ph.D.
To investigate the ideal time in culture to optimize embryo cell-free deoxyribonucleic acid (cfDNA) analysis in frozen-thawed blastocysts undergoing noninvasive preimplantation genetic testing for aneuploidy (PGT-A). Cell-free DNA is released into the spent blastocyst media (spent media) by the embryo. However, the optimal timing to determine maximal cfDNA in the case of frozen-thawed blastocysts undergoing
-
When should assisted reproductive technology workups be performed: following a tiered approach or all on day 1? Fertil. Steril. (IF 6.6) Pub Date : 2024-05-04 Dominique de Ziegler M.D., James P. Toner M.D. Ph.D., Richard T. Scott Jr. M.D., Paul Pirtea M.D.
-
Initial fertility evaluation with saline sonography vs. hysterosalpingography: it is debate-tubal Fertil. Steril. (IF 6.6) Pub Date : 2024-05-04 Edward Nguyen M.D. Ph.D., Michael Strug D.O. Ph.D., Austin Gardner M.D., Richard Burney M.Sc. M.D., Sukhkamal Campbell M.D., Lusine Aghajanova M.D. Ph.D.
-
The impact of obesity on reproductive health and metabolism in reproductive-age females Fertil. Steril. (IF 6.6) Pub Date : 2024-05-03 Samantha B. Schon M.D. M.T.R., Hannah E. Cabre Ph.D. R.D.N., Leanne M. Redman Ph.D.
Obesity is a highly prevalent chronic disease that impacts >40% of reproductive-aged females. The pathophysiology of obesity is complex and can be understood simply as a chronic energy imbalance whereby caloric intake exceeds caloric expenditure with an energy surplus stored in adipose tissue. Obesity may be categorized into degrees of severity as well as different phenotypes on the basis of metabolic
-
Anatomic fertility assessment: everything old is new again Fertil. Steril. (IF 6.6) Pub Date : 2024-05-03 Ruben Alvero M.D.
-
Urinary benzophenone-3 concentrations and ovarian reserve in a cohort of subfertile women Fertil. Steril. (IF 6.6) Pub Date : 2024-05-01 Emily L. Silva Ph.D. M.S., Lidia Mínguez-Alarcón Ph.D. M.P.H., Brent Coull Ph.D. M.S., Jaime E. Hart Sc.D., Tamarra James-Todd M.P.H. Ph.D., Antonia M. Calafat Ph.D., Jennifer B. Ford R.N. B.S.N., Russ Hauser M.D. M.P.H. Sc.D., Shruthi Mahalingaiah M.D. M.S.
To evaluate the association between the urinary benzophenone-3 concentrations and measures of ovarian reserve (OR) among women in the Environment and Reproductive Health study seeking fertility treatment at Massachusetts General Hospital (MGH) in Boston, Massachusetts. Prospective cohort study. MGH infertility clinic in Boston, Massachusetts. Women in the Environment and Reproductive Health cohort
-
When to say when: optimal number of intrauterine insemination treatment cycles Fertil. Steril. (IF 6.6) Pub Date : 2024-05-01 Robert T. Rydze M.D, Kate D. Schoyer M.D.
-
Fertility outcomes several years after urgent fertility preservation for patients with breast cancer Fertil. Steril. (IF 6.6) Pub Date : 2024-04-27 Maëliss Peigné M.D. Ph.D., Pauline Mur M.D., Laëtitia Laup M.D., Anne-Sophie Hamy M.D. Ph.D., Christophe Sifer M.D., Anne Mayeur M.D. Ph.D., Florence Eustache M.D. Ph.D., Solmaz Sarandi M.D., Claire Vinolas M.D., Sophia Rakrouki M.W., Alexandra Benoit M.W. Ph.D., Michaël Grynberg M.D. Ph.D., Charlotte Sonigo M.D. Ph.D.
To study the fertility outcomes of women who tried to conceive after breast cancer (BC) treatment and fertility preservation. Retrospective observational, bicentric cohort study. University hospital. Patients with BC. All patients who had undergone fertility preservation before BC treatment between January 2013 and July 2019 were included (n = 844). The endpoint date was March 1, 2022. Patients with
-
Noninvasive preimplantation genetic testing for aneuploidy—look before you leap Fertil. Steril. (IF 6.6) Pub Date : 2024-04-26 Francesca Barrett M.D. M.B.A., Thomas Molinaro M.D. M.S.C.E
-
Lessons in level-loading: how lean manufacturing principles can be utilized for fertility clinic optimization Fertil. Steril. (IF 6.6) Pub Date : 2024-04-26 Elizabeth B. Osmundsen M.D., Zoran J. Pavlovic M.D., Joshua C. Combs M.D.
-
Combined hysteroscopic Bigatti shaver (IBS) and resectoscope removal of a heterotopic cesarean scar pregnancy in the first trimester Fertil. Steril. (IF 6.6) Pub Date : 2024-04-25 Wei Liu M.D., Yang Yue M.D., Xiaoman Hou M.D., Huayu Han M.D., Wei Wang M.D., Xiaoyan Lin M.D.
To report a case of heterotopic cesarean scar pregnancy reduction using a combined hysteroscopic integrated Bigatti shaver (IBS) and resectoscope with the preservation of a normal gestational sac in the uterine cavity under simultaneous transabdominal ultrasound guidance. Video article. University-affiliated hospital. A 30-year-old woman, G5P2A2L2, with two previous cesarean deliveries and a history
-
Impact of time interval from cesarean delivery to frozen embryo transfer on reproductive and neonatal outcomes Fertil. Steril. (IF 6.6) Pub Date : 2024-04-23 Laura X. Zalles M.D., Kyle Le M.D., Samad Jahandideh Ph.D., Jiarui Wang M.S., Michael V. Homer M.D., Meike L. Uhler M.D., Luis R. Hoyos M.D., Kate Devine M.D., Janet Bruno-Gaston M.D.
To evaluate differences in reproductive and neonatal outcomes on the basis of the time interval from cesarean delivery to subsequent frozen embryo transfer (FET). Retrospective cohort. Multicenter fertility practice. Women undergoing autologous elective single embryo transfer FET after prior cesarean delivery. Time from prior cesarean delivery to subsequent FET. live birth (LB). A total of 6,556 autologous
-
Improving the quality of adenomyosis and racial disparities research Fertil. Steril. (IF 6.6) Pub Date : 2024-04-23 Kristen Upson M.P.H. Ph.D., Danielle R. Gartner M.S. Ph.D.
-
Response letter to “Some common, fatal flaws in systematic reviews of observational studies” Fertil. Steril. (IF 6.6) Pub Date : 2024-04-23 Sara E. Arian M.D. M.Sc., Shayan Mostafaei M.D.
-
Embryos don’t care if the sperm is there—intravaginal semen deposition does not increase pregnancy rates in in vitro fertilization Fertil. Steril. (IF 6.6) Pub Date : 2024-04-20 Sara C. Pierpoint M.D., Linnea R. Goodman M.D.
-
Assessment of pregnancy outcomes in donor oocyte thaw cycles comparing fresh embryo transfer to cryopreserved-thawed embryo transfer: a sibling oocyte study Fertil. Steril. (IF 6.6) Pub Date : 2024-04-19 Lauren Barrison M.D., Melissa Stratton B.A., Wayne Caswell M.S., Kate Devine M.D., Phillip A. Romanski M.D. M.Sc.
-
Influences of race, ethnicity, and other social factors on coronavirus disease 2019 vaccination uptake among patients undergoing in vitro fertilization Fertil. Steril. (IF 6.6) Pub Date : 2024-04-19 Leigh A. Humphries M.D., Jeremy Applebaum M.D., Florencia G. Polite M.D., Elizabeth Kravitz M.D., Clarisa R. Gracia M.D. M.S.C.E, Dara S. Berger Ph.D.
-
The effect of improved metabolic syndrome parameters on live birth Fertil. Steril. (IF 6.6) Pub Date : 2024-04-18 Trimble Spitzer M.D., Michael P. Diamond M.D., Robert Wild M.D. M.P.H. Ph.D., Richard Legro M.D., Heping Zhang Ph.D., Fangbai Sun M.P.H., Shen Ling Ph.D., Nanette Santoro M.D.
-
Hysteroscopic subchorionic injection of methotrexate followed by laparoscopic excision of the gestational sac for the management of cesarean scar ectopic pregnancy: an innovative dual approach of a challenging pathology Fertil. Steril. (IF 6.6) Pub Date : 2024-04-17 Maria del M. Tejerizo Fe M.D., Paola E. Benitez M.D., Alejandro M. Gonzalez M.D. Ph.D., Kyara Marquez M.D., Joelle Mouhanna M.D., Jose Carugno M.D.
To describe an effective two-step surgical approach for the management of cesarean scar ectopic pregnancies (CSEPs). CSEPs occur at an estimated frequency of 1 in 1,800 pregnancies, constituting approximately 6% of ectopic pregnancies in women with a history of prior cesarean delivery [1, 2]. Despite numerous recommended therapeutic approaches, the most effective treatment strategy remains uncertain
-
Classification and treatment of vaginal strictures at the donor-recipient anastomosis after uterus transplant Fertil. Steril. (IF 6.6) Pub Date : 2024-04-16 Liza Johannesson M.D. Ph.D., Leigh A. Humphries M.D., Paige M. Porrett M.D. Ph.D., Giuliano Testa M.D., Sophie Anderson, Jessica R. Walter M.D., Margaret Rush M.D., Cecile A. Ferrando M.D. M.P.H., Kathleen O’Neill M.D., Elliott G. Richards M.D. Ph.D.
To describe the incidence and management of vaginal stricture after uterus transplantation (UTx) in the US, to propose a grading system to classify stricture severity, and to identify risk factors for stricture formation. Prospective cohort study. University Hospital. Recipients undergoing UTx from 2016–2023 at Baylor University Medical Center in Dallas, Cleveland Clinic, the University of Pennsylvania
-
Laparoscopic removal of heterotopic cesarean scar pregnancy Fertil. Steril. (IF 6.6) Pub Date : 2024-04-16 Hakan Guraslan M.D., Ozlem K. Akgul M.D., Dogan E. Aydin M.D., Evrim E. Kovalak M.D., Nursen K. Aksoy M.D., Tugba O. Aydin M.D.
To present the laparoscopic management of heterotopic cesarean scar pregnancy and discuss other treatment options. Surgical video article. The Institutional Ethics Committee approved the video reproduction. Tertiary referral to a university hospital A 29-year-old woman with spontaneous heterotopic cesarean scar pregnancy presented for vaginal spotting. Ultrasound revealed two gestational sacs at 7